2012 IPO calendar building with 10 deals planned, pre-IPO research available

In the past three trading days, six companies have moved forward on their IPOs, bringing the total number of scheduled IPOs to 10. Renewable Energy Group (REGI) will kick off the 2012 IPO season with its pricing tonight. The company plans to raise $101 million by offering 7.2 million shares at a price range of $13.00 to $15.00. At the mid-point of the proposed range, Renewable Energy Group will command a market value of $401 million. In addition, three companies plan to price next week, and six companies plan to price the following week.

Next week's three deals include two technology firms. Guidewire (GWRE), which specializes in software for P&C insurance companies, announced that it would seek to raise $82.5 million by offering 7.5 million shares. Sales grew by 51% for the most recent quarter. IntelePeer (PEER), a cloud-based communications service provider, set terms for a $75 million offering on Tuesday. Its customers include Sprint Nextel and Qwest Communications.

Also expected next week is Verastem (VSTM), a developer of stem cell therapies for metastatic cancers, will offer 4.5 million shares at a price range of $9.00 to $11.00. At the midpoint of the proposed range, Verastem will command a market value of $196 million. Since its founding in August 2010, it has not generated any revenues and all product candidates are in preclinical studies. Longwood Fund (12% post-IPO stake), CHP III (10%), MPM Bioventures (10%) and Bessemer Venture Partners (10%) are listed as primary backers. Pricing is scheduled for January 26th.

Merrimack Pharmaceuticals (MACK), a biopharmaceutical company focused on cancer treatments, will offer 16.7 million shares at a price range of $8.00 to $10.00. At the midpoint of the proposed range, Merrimack will command a market value of $984 million. Merrimack has five product candidates and, up to this point, all revenues have been research-related. Sanofi paid a license fee for one product candidate and another candidate has passed Phase 2 trials for the treatment of metastatic pancreatic cancer. Pricing is scheduled for January 31st.

Cempra (CEMP), which researches treatments for bacterial infectious diseases, will offer 6 million shares at a price range of $11.00 to $13.00. At the midpoint of the proposed range, Cempra will command a market value of $195 million. Although it has yet to generate revenues, its top two product candidates have both passed Phase 2 clinical trials. Pricing is set for the week of January 30th (specific date TBA).

Dynamic Offshore Resources (DOR), a U.S.-based oil and natural gas E&P, will offer 16.7 million shares at a price range of $17.00 to $19.00. At the midpoint of the proposed range, the market value will be approximately $1.3 billion. Dynamic Offshore is backed by Riverstone and The Carlyle Group. Pricing is scheduled for January 31st.

U.S. Silica Holdings (SLCA), the second largest domestic producer of commercial silica, will offer 11.7 million shares (75% insider) at a price range of $16.00 to $18.00. At the midpoint of the proposed range, U.S. Silica will command a market value of $900 million. For the nine months ended September 30, 2011, sales grew 14% to $212 million. Pricing is set for January 31st.

AVG Technologies (AVG), a security software company using a freemium pricing model, will offer 8 million shares (50% insider) at a price range of $16.00 to $18.00. At the midpoint of the proposed range, AVG will command a market value of $925 million. Its free antivirus product has the most downloads of any software on CNET's Download.com. For the nine months ended September 30, 2011, sales grew 24% to $198 million. Pricing is scheduled for February 1st.

Greenway Medical Technologies (GWAY), a provider of integrated information technology solutions to ambulatory healthcare providers, announced terms for its IPO on Wednesday. The Carrollton, GA-based company plans to raise $80 million by offering 6.7 million shares at a price range of $11.00 to $13.00. At the mid-point of the proposed range, it will command a market value of $347 million. Greenway, which was founded in 1998, booked $99 million in sales for the 12 months ended September 30, 2011. Revenues grew by 55% in the most recent quarter. Pricing is scheduled for February 1st.